Clinical Trial of FCN-437c Capsule in Patients With Hepatic Insufficiency

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 4, 2023

Primary Completion Date

September 27, 2023

Study Completion Date

September 27, 2023

Conditions
Hepatic Insufficiency
Interventions
DRUG

FCN-437c capsule

Take 200 mg of FCN-437c capsules with approximately 240 mL of warm water in the morning on an empty stomach.

Trial Locations (1)

130021

The First Hospital of Jilin University, Changchun

Sponsors
All Listed Sponsors
lead

Ahon Pharmaceutical Co., Ltd.

OTHER

NCT06620731 - Clinical Trial of FCN-437c Capsule in Patients With Hepatic Insufficiency | Biotech Hunter | Biotech Hunter